Photo by sxy_selia from unsplash
Abstract Vaccine solutions rarely reach the public until after an outbreak abates; an Ebola vaccine was approved 5-years after peak outbreak and SARS, MERS, and Zika vaccines are still in… Click to show full abstract
Abstract Vaccine solutions rarely reach the public until after an outbreak abates; an Ebola vaccine was approved 5-years after peak outbreak and SARS, MERS, and Zika vaccines are still in clinical development. Despite massive leaps forward in rapid science, other regulatory bottlenecks are hamstringing the global effort for pandemic vaccines.
Keywords:
working hard;
working regulatory;
hard hardly;
regulatory bottlenecks;
hardly working;
vaccine
Journal Title: Trends in Biotechnology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Trends in Biotechnology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!